Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score’s prediction factor for survival?

BACKGROUND AND AIM: Radioembolization (RE) is a one of the palliative treatments that have been used to down stage and/or increase the survival time in intermediate-advanced stages of HCC. We aimed to evaluate the clinical impact of RE and the clinical use of the albumin-bilirubin (ALBI) score as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Evirgen, Sami, Cavus, Bilger, Gokturk, Suut, Iliaz, Raim, Ozkan, Zeynep Gozde, Baran, Bulent, Ormeci, Asli Ciftcibası, Soyer, Ozlem Mutluay, Karaca, Cetin, Demir, Kadir, Besisik, Selman Fatih, Poyanli, Arzu, Akyuz, Filiz, Kaymakoglu, Sabahattin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564249/
https://www.ncbi.nlm.nih.gov/pubmed/37822305
http://dx.doi.org/10.14744/hf.2022.2022.0036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564249/
https://www.ncbi.nlm.nih.gov/pubmed/37822305
http://dx.doi.org/10.14744/hf.2022.2022.0036

Ejemplares similares